Search
for
Sort by
Research 91–120 of 1000+
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Comparative Efficacy and Adverse Clinical Events of Methotrexate versus Azathioprine with Steroid Mini Pulse Therapy in the Management of Moderate to Severe Alopecia Areata: A Tertiary Centre Based Interventional Study
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- Reporting on Adverse Clinical Events
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Finasteride: suicidality or psychological adverse events
- Faculty Opinions recommendation of Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- A rare adverse event following laser hair reduction
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Clinical development and management of adverse events associated with FGFR inhibitors
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- FDA Reports of Alopecia as an Adverse Event to Isotretinoin
- Clinical perspective on management of key adverse events with sacituzumab govitecan
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)